DCM
SPPI

DAFNA Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

DAFNA Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-197,500
Closed -$644K – 95
2021
Q1 		$644K Buy
+197,500
New +$708K 0.15% 81
2020
Q4 		– Sell
-514,891
Closed -$2.1M – 87
2020
Q3 		$2.1M Buy
+514,891
New +$1.96M 0.68% 39

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

DAFNA Capital Management's SPPI Position: Q2 2021 in Review

DAFNA Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2021, closing a stake of 197,500 shares — an estimated $644K sold.

DAFNA Capital Management first reported a position in SPPI in Q3 2020 and held it in 2 quarters. The position peaked at $2.1M in Q3 2020. 156 funds tracked by Wall St. Rank hold SPPI as of Q2 2021.

  • DAFNA Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • DAFNA Capital Management sold 197,500 Spectrum Pharmaceuticals Inc shares in Q2 2021, an estimated $644K.
  • DAFNA Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2020 and held it in 2 quarters.
  • DAFNA Capital Management's Spectrum Pharmaceuticals Inc position peaked at $2.1M in Q3 2020.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2021.

Based on DAFNA Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.